Home > ASQ Washington, DC &... > Events > Attend an Event > June Biomed/BioTech SIG...
Printable Version
Tell a friend
June Biomed/BioTech SIG Meeting
Where
Kelly's Deli Conference Center
Next to the entrance to 7519 Standish Drive
FDA/CVM Center
Rockville, Maryland 20855
When
Jun 11, 2009
6:00 pm - 9:15 pm
“Medication Errors 101!”
Presented by
Linda
Y. Kim-Jung, PharmD
Consumer Safety
Officer
Medical Review and Pharmacovigilance
Team, Division of Surveillance
Office of
Surveillance and Compliance
Center for
Veterinary Medicine, FDA
And
“Steps to a Quality CBER Submission”
Presented by
Ms.
Susan Yu
Lead Regulatory Quality
Manager
Division of Manufacturing and
Product Quality
Office of Compliance and
Biologics Quality
Center for Biologics
Evaluation and Review (CBER), FDA
Thursday, June 11, 2009
at
The Kelly’s Deli
Conference Room
7519 Standish
Place, Rockville, MD 20855
6:00 - 6:15 pm: Networking with
a light pizza dinner
6:15 - 9:00 pm:
Program
9:00 - 9:15 pm: Door prize drawing
and networking
Costs: Free to the general public with a door prize drawing
Registration: To register for this meeting, please click here by Thursday noon, June 11, 2009.
Event Contact: Dr. George
Chang at gchang2008@yahoo.com
or 240-793-8425.
Program
Summary:
Medication Errors
101. This presentation will include a
general introduction about the sources of drug
risks followed by a summary of the current
medication error prevention initiatives in FDA.
The focus of the talk will be in regards to the
trade-name confusion and error-prone
label/labeling issues. Lastly, about how
medication error prevention and analysis ties
into the overall efforts of promoting drug
safety will be discussed.
Steps to a Quality CBER Submission. The speaker will provide an overview of the steps to consider when preparing a submission for CBER from a facility and current good manufacturing practice reviewer’s viewpoint. The speaker will provide an overview of the CBER review process and products; identify resources that can be used when preparing a submission; discuss statutes and regulations that must be followed; review steps that may be used to help an efficient CBER review and inspection; review submission pitfalls; and provide comments from reviewers about problems encountered in submissions and during inspection.
For more information and directions to the meeting, see the June 11, 2009 Biomed/Biotech SIG Meeting Announcement.
Add To Outlook
Add To Google
